Literature DB >> 29369517

Causes and timing of end-stage renal disease after living kidney donation.

Arthur J Matas1, Danielle M Berglund2, David M Vock3, Hassan N Ibrahim4.   

Abstract

End-stage renal disease (ESRD) is a risk after kidney donation. We sought, in a large cohort of kidney donors, to determine the causes of donor ESRD, the interval from donation to ESRD, the role of the donor/recipient relationship, and the trajectory of the estimated GFR (eGFR) from donation to ESRD. From 1/1/1963 thru 12/31/2015, 4030 individuals underwent living donor nephrectomy at our center, as well as ascertainment of ESRD status. Of these, 39 developed ESRD (mean age ± standard deviation [SD] at ESRD, 62.4 ± 14.1 years; mean interval between donation and ESRD, 27.1 ± 9.8 years). Donors developing ESRD were more likely to be male, as well as smokers, and younger at donation, and to have donated to a first-degree relative. Of donors with a known cause of ESRD (n = 25), 48% was due to diabetes and/or hypertension; only 2 from a disease that would have affected 1 kidney (cancer). Of those 25 with an ascertainable ESRD cause, 4 shared a similar etiology of ESRD with their recipient. Almost universally, thechange of eGFR over time was stable, until new-onset disease (kidney or systemic). Knowledge of factors contributing to ESRD after living kidney donation can improve donor selection and counseling, as well as long-term postdonation care.
© 2018 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  clinical research/practice; donor follow-up; donor nephrectomy; donors and donation; glomerular filtration rate (GFR); health services and outcomes research; hypertension/antihypertensives; kidney (native) function/dysfunction; kidney transplantation/nephrology

Mesh:

Year:  2018        PMID: 29369517     DOI: 10.1111/ajt.14671

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  16 in total

1.  Risk of ESKD in Older Live Kidney Donors with Hypertension.

Authors:  Fawaz Al Ammary; Xun Luo; Abimereki D Muzaale; Allan B Massie; Deidra C Crews; Madeleine M Waldram; Mohamud A Qadi; Jacqueline Garonzik-Wang; Macey L Henderson; Daniel C Brennan; Alexander C Wiseman; Richard C Lindrooth; Jon J Snyder; Josef Coresh; Dorry L Segev
Journal:  Clin J Am Soc Nephrol       Date:  2019-06-25       Impact factor: 8.237

Review 2.  Hyperfiltration-mediated Injury in the Remaining Kidney of a Transplant Donor.

Authors:  Tarak Srivastava; Sundaram Hariharan; Uri S Alon; Ellen T McCarthy; Ram Sharma; Ashraf El-Meanawy; Virginia J Savin; Mukut Sharma
Journal:  Transplantation       Date:  2018-10       Impact factor: 4.939

3.  Self-Reported Incident Hypertension and Long-Term Kidney Function in Living Kidney Donors Compared with Healthy Nondonors.

Authors:  Courtenay M Holscher; Christine E Haugen; Kyle R Jackson; Jacqueline M Garonzik Wang; Madeleine M Waldram; Sunjae Bae; Jayme E Locke; Rhiannon D Reed; Krista L Lentine; Gaurav Gupta; Matthew R Weir; John J Friedewald; Jennifer Verbesey; Matthew Cooper; Dorry L Segev; Allan B Massie
Journal:  Clin J Am Soc Nephrol       Date:  2019-09-19       Impact factor: 8.237

Review 4.  Risks of Living Kidney Donation: Current State of Knowledge on Outcomes Important to Donors.

Authors:  Krista L Lentine; Ngan N Lam; Dorry L Segev
Journal:  Clin J Am Soc Nephrol       Date:  2019-03-11       Impact factor: 8.237

Review 5.  The present and future of transplant organ shortage: some potential remedies.

Authors:  Bahar Bastani
Journal:  J Nephrol       Date:  2019-08-09       Impact factor: 3.902

6.  The changing landscape of live kidney donation in the United States from 2005 to 2017.

Authors:  Fawaz Al Ammary; Mary Grace Bowring; Allan B Massie; Sile Yu; Madeleine M Waldram; Jacqueline Garonzik-Wang; Alvin G Thomas; Courtenay M Holscher; Mohamud A Qadi; Macey L Henderson; Alexander C Wiseman; Jane Gralla; Daniel C Brennan; Dorry L Segev; Abimereki D Muzaale
Journal:  Am J Transplant       Date:  2019-05-03       Impact factor: 8.086

7.  Understanding Risks and Our Responsibility to Living Donors.

Authors:  John S Gill; Jesse Schold; Bruce Kaplan
Journal:  J Am Soc Nephrol       Date:  2021-11       Impact factor: 10.121

8.  Living Donors: Caring for the Trailblazers of Progress in Transplantation.

Authors:  Ashley Lau; Rebecca E Scully; Mats Brännström; Stefan G Tullius
Journal:  Transplantation       Date:  2018-11       Impact factor: 4.939

9.  Association of Early Postdonation Renal Function With Subsequent Risk of End-Stage Renal Disease in Living Kidney Donors.

Authors:  Allan B Massie; Courtenay M Holscher; Macey L Henderson; Lara M Fahmy; Alvin G Thomas; Fawaz Al Ammary; Samantha N Getsin; Jon J Snyder; Krista L Lentine; Amit X Garg; Dorry L Segev
Journal:  JAMA Surg       Date:  2020-03-18       Impact factor: 14.766

10.  Transcription Factor β-Catenin Plays a Key Role in Fluid Flow Shear Stress-Mediated Glomerular Injury in Solitary Kidney.

Authors:  Tarak Srivastava; Daniel P Heruth; R Scott Duncan; Mohammad H Rezaiekhaligh; Robert E Garola; Lakshmi Priya; Jianping Zhou; Varun C Boinpelly; Jan Novak; Mohammed Farhan Ali; Trupti Joshi; Uri S Alon; Yuexu Jiang; Ellen T McCarthy; Virginia J Savin; Ram Sharma; Mark L Johnson; Mukut Sharma
Journal:  Cells       Date:  2021-05-19       Impact factor: 7.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.